30354828 26629175 30194545 26102475 26956230 34101968 30354654 26011377 28882918 26435037 27777360 27457472 34950242 32870176 26084656 33370170 29133356 25385345 34066713 26115629 27798457 27224417 30580680 33932429 26852290 30041793 30142317 3200843 - Search Results

Year	Number of Results
2014	2
2015	6
2016	10
2017	6
2018	8
2019	5
2020	5
2021	8
2022	1

1

Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association.

Carey RM, Calhoun DA, Bakris GL, Brook RD, Daugherty SL, Dennison-Himmelfarb CR, Egan BM, Flack JM, Gidding SS, Judd E, Lackland DT, Laffer CL, Newton-Cheh C, Smith SM, Taler SJ, Textor SC, Turan TN, White WB; American Heart Association Professional/Public Education and Publications Committee of the Council on Hypertension; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Genomic and Precision Medicine; Council on Peripheral Vascular Disease; Council on Quality of Care and Outcomes Research; and Stroke Council. Carey RM, et al. Hypertension. 2018 Nov;72(5):e53-e90. doi: 10.1161/HYP.0000000000000084. Hypertension. 2018. PMID: 30354828 Free PMC article.

2

Analysis of high risk factors and characteristics of coronary artery in premenopausal women with coronary artery disease.

Li Z, Cheng J, Wang L, Yan P, Liu X, Zhao D. Li Z, et al. Int J Clin Exp Med. 2015 Sep 15;8(9):16488-95. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26629175 Free PMC article.

3

Modulation of Sympathetic Overactivity to Treat Resistant Hypertension.

Voora R, Hinderliter AL. Voora R, et al. Curr Hypertens Rep. 2018 Sep 7;20(11):92. doi: 10.1007/s11906-018-0893-8. Curr Hypertens Rep. 2018. PMID: 30194545 Review.

4

Reducing women's cardiovascular disease risk profile.

Kurth J, Malik S. Kurth J, et al. Womens Health (Lond). 2015 Jun;11(3):385-97. doi: 10.2217/whe.15.10. Womens Health (Lond). 2015. PMID: 26102475 Free article.

5

Risk Factors for Myocardial Infarction in Women and Men: A Review of the Current Literature.

Pedersen LR, Frestad D, Michelsen MM, Mygind ND, Rasmusen H, Suhrs HE, Prescott E. Pedersen LR, et al. Curr Pharm Des. 2016;22(25):3835-52. doi: 10.2174/1381612822666160309115318. Curr Pharm Des. 2016. PMID: 26956230 Review.

6

Eligibility for Baroreflex Activation Therapy and medication adherence in patients with apparently resistant hypertension.

Schäfer AK, Kuczera T, Wurm-Kuczera R, Müller D, Born E, Lipphardt M, Plüss M, Wallbach M, Koziolek M. Schäfer AK, et al. J Clin Hypertens (Greenwich). 2021 Jul;23(7):1363-1371. doi: 10.1111/jch.14302. Epub 2021 Jun 8. J Clin Hypertens (Greenwich). 2021. PMID: 34101968 Free PMC article.

7

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith SC Jr, Spencer CC, Stafford RS, Taler SJ, Thomas RJ, Williams KA Sr, Williamson JD, Wright JT Jr. Whelton PK, et al. Circulation. 2018 Oct 23;138(17):e484-e594. doi: 10.1161/CIR.0000000000000596. Circulation. 2018. PMID: 30354654 No abstract available.

8

Coronary microvascular dysfunction: sex-specific risk, diagnosis, and therapy.

Dean J, Cruz SD, Mehta PK, Merz CN. Dean J, et al. Nat Rev Cardiol. 2015 Jul;12(7):406-14. doi: 10.1038/nrcardio.2015.72. Epub 2015 May 26. Nat Rev Cardiol. 2015. PMID: 26011377 Review.

9

Prevalence and clinical characteristics of apparent therapy-resistant hypertension in patients with cardiovascular disease: a cross-sectional cohort study in secondary care.

de Beus E, van der Sande NGC, Bots ML, Spiering W, Voskuil M, Visseren FLJ, Blankestijn PJ. de Beus E, et al. BMJ Open. 2017 Sep 6;7(9):e016692. doi: 10.1136/bmjopen-2017-016692. BMJ Open. 2017. PMID: 28882918 Free PMC article.

10

Resistant Hypertension and Susceptible Outcomes: Exploring the Benefits of Aggressive Blood Pressure Control.

Smith SM. Smith SM. J Clin Hypertens (Greenwich). 2016 Jan;18(1):40-2. doi: 10.1111/jch.12677. Epub 2015 Oct 5. J Clin Hypertens (Greenwich). 2016. PMID: 26435037 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results